Atezolizumab

Common brands: Tecentriq, Avastin, Carboplatin, Kyxata, Abraxane

Top reporter: Genentech, Inc.

Programmed Death Receptor-1 Blocking Antibody [EPC]Vascular Endothelial Growth Factor Inhibitor [EPC]Platinum-based Drug [EPC]Microtubule Inhibitor [EPC]Topoisomerase Inhibitor [EPC]
37,421
Total Reports
22,926
Serious Reports
9,568
Death Reports
30
Reported Reactions
Death Report Ratio: High (25.57%)

Patient Demographics

Male
19,670
Female
11,655

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Atezolizumab.

# Reaction Reports % of Total
1 DEATH 4,166
11.8%
2 OFF LABEL USE 3,424
9.7%
3 DISEASE PROGRESSION 2,076
5.9%
4 PYREXIA 1,712
4.9%
5 DIARRHOEA 1,681
4.8%
6 FATIGUE 1,450
4.1%
7 ANAEMIA 1,308
3.7%
8 PNEUMONIA 1,099
3.1%
9 DECREASED APPETITE 1,077
3.1%
10 NAUSEA 1,034
2.9%
11 HYPOTHYROIDISM 1,027
2.9%
12 DYSPNOEA 1,000
2.8%
13 HYPERTENSION 971
2.8%
14 PNEUMONITIS 933
2.6%
15 FEBRILE NEUTROPENIA 929
2.6%
16 RASH 924
2.6%
17 ASTHENIA 908
2.6%
18 INTERSTITIAL LUNG DISEASE 810
2.3%
19 INTENTIONAL PRODUCT USE ISSUE 800
2.3%
20 NEUTROPENIA 798
2.3%
21 THROMBOCYTOPENIA 798
2.3%
22 VOMITING 789
2.2%
23 COLITIS 762
2.2%
24 HEPATOCELLULAR CARCINOMA 744
2.1%
25 PLATELET COUNT DECREASED 738
2.1%
26 ACUTE KIDNEY INJURY 717
2.0%
27 PROTEINURIA 688
1.9%
28 DRUG INEFFECTIVE 678
1.9%
29 CONSTIPATION 628
1.8%
30 NEUTROPHIL COUNT DECREASED 618
1.8%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.